Lipid Profile clinical trials

Explore recruiting lipid profile clinical trials.

Recruiting lipid profile studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lipid Profile trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, double-blind and multicentric study to assess the efficiency, security and tolerability of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis (EMOTION)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Low dose TamOxifen and LifestylE changes for bReast cANcer prevenTion: a randomized phase II biomarker trial in subjects at increased risk (TOLERANT Study)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Does the glucagon-like peptide-1 receptor agonist semaglutide prevent deterioration of metabolic state in prediabetic or diabetic patients with schizophrenia treated with the antipsychotic compounds clozapine or olanzapine?

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, double-blind and multicentric study to assess the efficiency, security and tolerability of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis (EMOTION)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Once Weekly s.c. Administered GL0034 in Adults with Type 2 Diabetes Mellitus Inadequately controlled on Metformin Or Diet and Exercise

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Vonafexor fixed dose-escalation safety and proof-of-concept study in patients with at risk of progression Alport syndrome

Spain, France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Lipid Profile trials by city

Lipid Profile in Toronto Lipid Profile in Vancouver Lipid Profile in Montreal Lipid Profile in Calgary Lipid Profile in Edmonton Lipid Profile in Ottawa Lipid Profile in Winnipeg Lipid Profile in Quebec City Lipid Profile in Hamilton Lipid Profile in Kitchener Lipid Profile in London Lipid Profile in Halifax Lipid Profile in New York Lipid Profile in Los Angeles Lipid Profile in Chicago Lipid Profile in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease